Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study
- PMID: 35457498
- PMCID: PMC9025920
- DOI: 10.3390/ijerph19084631
Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study
Abstract
This study aimed to examine the incidence and predictors of loss to follow up (LTFU) in the context of ongoing atrocities caused by armed conflict, where HIV treatment programs and HIV-infected patients may face unique challenges in terms of ART adherence and retention in care. We conducted an observational prospective cohort study of 468 patients living with HIV (PLWHIV) under dolutegravir (DTG) in all health facilities in Bunia between July 2019 and July 2021. Kaplan-Meier plots were used to determine the probability of LTFU as a function of time as inclusive of the cohort. The main outcome variable was LTFU, defined as not taking an ART refill for a period of 3 months or longer from the last attendance for refill, and not yet classified as 'dead' or 'transferred-out.' The log-rank test was used to compare survival curves based on predictors. Cox proportional hazard modeling was used to measure predictors of LTFU from the baseline until 31 July 2021 (the endpoint). A total of 3435.22 person-months (p-m) were involved in follow up, with an overall incidence rate of 33.48 LTFU per 1000 p-m. Patients who had less experience with ART at enrolment and the ethnically Sudanese, had a higher hazard of being LTFU compared to their reference groups. This study reports a high LTFU rate in this conflict setting. An ART program in such a setting should pay more attention to naive patients and other particularly vulnerable patients such as Sudanese during the pre-ART phase. The study implies the implementation of innovative strategies to address this high risk of being LTFU, reducing either the cost or the distance to the health facility.
Keywords: Bunia; HIV patient loss to follow up; RDC; anti-retroviral therapy; armed conflict.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Laborde-Balen G., Taverne B., Ndoye I. Ne Pas Baisser la Garde !: L’Inquiétante Progression Des échecs Thérapeutiques Face au VIH en Afrique Sub-Saharienne. Face à Face Regards Sur Santé. [(accessed on 2 December 2021)]. Available online: https://journals.openedition.org/faceaface/1632.
-
- Ba S., Ba N.D., Sembene L., Anne T.S.B., Dia H., Ndiaye J.L., Badiane N.M.D., Ndour C.T. Factors Associated with Adverse Therapeutic Outcomes in People Living with HIV (PLHIV) Monitored in Roi Baudouin Health Care Center, Dakar, Senegal. World J. AIDS. 2020;10:23–35. doi: 10.4236/wja.2020.101003. - DOI
-
- PNLS National . Manuel de Formation du Tutorat sur la Prévention, Soins et Traitement du VIH/SIDA et les IST en RDC. PNLS National; Kinshasa, Democratic Republic of the Congo: 2018.
-
- Gupta A.K., Dabla V., Joshi B.C., Chakraborty S., Baishya J.J., Gupta A. Challenges in Retention of Patients in Continuum of HIV-Care in Delhi—Experience of a Decade & Way Ahead. World J. AIDS. 2014;4:387–395.
-
- PNLS Ituri . Rapport Annuel des Activités de Lutte Contre le VIH/SIDA et les IST dans la Province de l’Ituri en RDC. PNLS; Ituri, Democratic Republic of the Congo: 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
